Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (141-150 of 487) with videos related to

Pageof 49
Sort By:
Current Oncology Reports|October 15, 2017
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular MicroscopeRoman Groisberg, Jason Roszik, Anthony Conley, et al.
Molecular Cancer Therapeutics|June 1, 2023
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and BiomarkersBlessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth, et al.
The Lancet. Oncology|February 5, 2026
Factors that can make overall survival unreliable as a clinical trial outcomeDavid J Stewart, Vivek Subbiah, Mathew Vogel, et al.
Nature Reviews. Clinical Oncology|June 6, 2025
Surrogate end points in oncology: aligning drug development incentives and patient needsMatthew Vogel, Rona Yaeger, David J Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2023
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical ImplicationsMohamed A Gouda, Blessie E Nelson, Lars Buschhorn, et al.
Journal of Clinical Medicine|June 19, 2024
Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase InhibitorsKalevi Kairemo, Mohamed Gouda, Hubert H Chuang, et al.
CA: a Cancer Journal for Clinicians|May 30, 2024
The evolving landscape of tissue-agnostic therapies in precision oncologyVivek Subbiah, Mohamed A Gouda, Bettina Ryll, et al.
Trends in Cancer|December 10, 2021
Impact of tissue-agnostic approvals for patients with sarcomaRoberto Carmagnani Pestana, Juliana Rodrigues Beal, Amanda Parkes, et al.
Cell|January 18, 2020
The Master Observational Trial: A New Class of Master Protocol to Advance Precision MedicineDane Dickson, Jennifer Johnson, Raymond Bergan, et al.
British Journal of Cancer|March 14, 2023
The emerging role of PI3K inhibitors for solid tumour treatment and beyondCarmen Belli, Matteo Repetto, Santosh Anand, et al.
Pageof 49

Showing results (141-150 of 487) with videos related to

Sort By:
Pageof 49
Current Oncology Reports|October 15, 2017
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular MicroscopeRoman Groisberg, Jason Roszik, Anthony Conley, et al.
Molecular Cancer Therapeutics|June 1, 2023
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and BiomarkersBlessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth, et al.
The Lancet. Oncology|February 5, 2026
Factors that can make overall survival unreliable as a clinical trial outcomeDavid J Stewart, Vivek Subbiah, Mathew Vogel, et al.
Nature Reviews. Clinical Oncology|June 6, 2025
Surrogate end points in oncology: aligning drug development incentives and patient needsMatthew Vogel, Rona Yaeger, David J Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2023
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical ImplicationsMohamed A Gouda, Blessie E Nelson, Lars Buschhorn, et al.
Journal of Clinical Medicine|June 19, 2024
Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase InhibitorsKalevi Kairemo, Mohamed Gouda, Hubert H Chuang, et al.
CA: a Cancer Journal for Clinicians|May 30, 2024
The evolving landscape of tissue-agnostic therapies in precision oncologyVivek Subbiah, Mohamed A Gouda, Bettina Ryll, et al.
Trends in Cancer|December 10, 2021
Impact of tissue-agnostic approvals for patients with sarcomaRoberto Carmagnani Pestana, Juliana Rodrigues Beal, Amanda Parkes, et al.
Cell|January 18, 2020
The Master Observational Trial: A New Class of Master Protocol to Advance Precision MedicineDane Dickson, Jennifer Johnson, Raymond Bergan, et al.
British Journal of Cancer|March 14, 2023
The emerging role of PI3K inhibitors for solid tumour treatment and beyondCarmen Belli, Matteo Repetto, Santosh Anand, et al.
Pageof 49